Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
13.24
-0.26 (-1.93%)
May 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Sterigenics | 701.04M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sterigenics Growth | 4.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion | 181.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Growth | 3.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs | 223.84M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Growth | -1.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | 939.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | 2.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | 167.51M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | 5.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Sterigenics Capital Expenditures | 125.38M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sterigenics Capital Expenditures Growth | -26.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Capital Expenditures | 26.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Capital Expenditures Growth | -77.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Capital Expenditures | 12.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Capital Expenditures Growth | -39.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Sterigenics Segment Income | 380.36M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sterigenics Segment Income Growth | 4.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Segment Income | 107.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Segment Income Growth | 1.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Segment Income | 70.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Segment Income Growth | -0.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2019 |
| United States |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|